People with blood type O are significantly less likely to develop multiple myeloma, but those who do are likely to have more aggressive disease and poorer survival outcomes, a study found. The study, “Effect of the ABO blood groups on the development, clinical features and survival of multiple myeloma,” was published in the journal Magazine of European Medical Oncology. ABO blood groups are based on different carbohydrates on the surface of red blood cells, and…
You must be logged in to read/download the full post.
The post Blood Type O Lowers Myeloma Risk, But Outcomes Typically Worse appeared first on BioNewsFeeds.